SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001376474-24-000167
Filing Date
2024-04-16
Accepted
2024-04-16 16:39:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G alpi_sc13g.htm SC 13G 28391
  Complete submission text file 0001376474-24-000167.txt   29948
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91201 | Film No.: 24848314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9559 COLLINS AVE, APT 1099S MIAMI FL 33154
Business Address 9559 COLLINS AVE, APT 1099S MIAMI FL 33154 845-570-1240
ALPHA PHARMA Investments LLC (Filed by) CIK: 0002018003 (see all company filings)

IRS No.: 991963468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G